共 14 条
- [1] Jones G.J., Itri L.M., Safety and tolerance of recombinant interferon alfa-2a (Roferon<sup>r`</sup>-A) in cancer patients, Cancer, 57, pp. 1709-1715, (1986)
- [2] Quesada J.R., Talpaz M., Rios A., Et al., Clinical toxicity of interferon in cancer patients: A review, J Clin Oncol, 4, pp. 234-243, (1986)
- [3] Kurschel E., Metz-Kurschel U.M., Niederle N., Et al., Investigations on the subclinical and clinical nephrotoxicity of interferon alfa-2B in patients with myeloproliferative syndromes, Renal Failure, 13, pp. 87-93, (1991)
- [4] Silva M.O., Reddy K.R., Jeffers L.J., Hill M., Schiff E.R., Interferon induced chronic active hepatitis?, Gastroenterology, 101, pp. 840-842, (1991)
- [5] Gresser J., Interferon-induced disease, The Biology of the Interferon System, pp. 363-368, (1983)
- [6] Averbruck S.D., Austin H.A., Sherwin S.A., Et al., Acute interstitial nephritis with the nephrotic syndrome following recombinant A interferon therapy for mycosis fungoides, N Engl J Med, 310, pp. 32-35, (1984)
- [7] Selby P., Kohn J., Raymond J., Judson I., Et al., Nephrotic syndrome during treatment with interferon, Br Med J, 290, (1985)
- [8] Sriskandan K., Tee O.S.H., Pettingale K.W., Nephrotic syndrome during treatment with inteferon, Br Med J, 290, pp. 1590-1591, (1985)
- [9] Woodrow D., Ronco P., Riviere Y., Et al., Severity of glomerulo-nephritis induced in different strains of mice by infection with lymphocytic choriomeningitis virus. Correlation with amounts of endogenous interferon and circulating immune complexes, J Pathol, 138, pp. 325-336, (1982)
- [10] Killen P.D., Melcion C., Bonadio J.F., Et al., Glomerular response to immunologic injury, studies on progression, Springer Semin Im-munopathol, 138, pp. 325-336, (1982)